/
Neurofeedback  for  Insomnia Neurofeedback  for  Insomnia

Neurofeedback for Insomnia - PowerPoint Presentation

stefany-barnette
stefany-barnette . @stefany-barnette
Follow
348 views
Uploaded On 2018-10-30

Neurofeedback for Insomnia - PPT Presentation

A New Look at an Old Workhorse A Pilot Study of Z Score Sensorimotor amp Individualized Neurofeedback See full text at Hammer BU Colbert AP Brown KA and Ilioi E C 2011 Neurofeedback for Insomnia A Pilot Study of ZScore SMR and Individualized Protocols Appl ID: 703839

insomnia sleep measures smr sleep insomnia smr measures training amp nfb score treatment time post screening improved quality significant

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Neurofeedback for Insomnia" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Neurofeedback for Insomnia

A New Look at an Old Workhorse: A Pilot Study of

Z

-Score Sensorimotor & Individualized Neurofeedback

See full text at: Hammer, B.U., Colbert, A.P., Brown, K.A. and Ilioi, E. C. (2011). Neurofeedback for Insomnia: A Pilot Study of Z-Score SMR and Individualized Protocols. Appl.

Psychophysiol

Biofeedback, DOI 10.1007/s10484-011-9165-y

Email: barbhammer37@yahoo.comSlide2

Barbara U. Hammer, Ph.D., Agatha P. Colbert, MD

,

Kimberly A. Brown, MSOM, Helfgott Research Institute, National College of Natural Medicine, Portland, OR, Elena C. Ilioi, Psychology Honours, McGill University, Montreal, Quebec, Canada

The authors are grateful to the Helfgott Research Institute of the National College of Natural Medicine in Portland, Oregon for its generous support of this research. We are especially appreciative of the help from Mark L. Smith and Nancy Wigton on the design of the protocols, William Gregory and Heather Jaskirat Wild for her assistance

with the

data analysis, and the generous support of our research assistants, Sean E. Griffith and Tineke Malus. We thank all those who participated in this study, including those who took the time to complete the telephone screening and the extended screening sessions but who were not offered the opportunity to continue and to receive treatment.

 Slide3

Insomnia Definition

Primary Insomnia (DSM 307.44)

:

Complaints of Difficulty Falling Asleep, Staying Asleep or Awakening too early, or Non-restorative Sleep which occurs for at least one month and:

1. Causes significant distress or impairment in social, occupational, or other important areas of functioning.

2. Does not occur exclusively during the course of Narcolepsy, Breathing-Related Disorder, Circadian Rhythm Sleep Disorder or a

Parasomnia

.

3. Does not occur exclusively during the course of another mental disorder.

4. Is not due to the direct physiological effects of a substance or general medical condition

.

Slide4

2005 NIH Conference on Insomnia declared Insomnia

an

Epidemic:20-30% of adults in the U.S. suffer from Insomnia\

Insomnia associated

with

increased

Illness, accidents, healthcare utilization, and industrial expenses

Costs estimated at $14-80 billion annually

Pharmacotherapy limited due to negative

side effectsSlide5

Psychological treatments

highest co-morbidity

Insomnia

persists despite psychotherapy for

depression

or

anxiety

Cognitive

Behavior Therap

y

demonstrated

70% efficacy , effectiveness, efficiency for

treatment of

Insomnia but seldom used

difficult to

administer requiring specialized training/many sessions

Challenges remain primarily in service delivery system.

Internet based program promising

Neurofeedback

SMR

from Sterman 1960’s to Hauri (1980’s

)=cats to humans, improved

sleep

Theta

benefitted tense insomniacs

Individualized

studied hereSlide6

Peter Hauri (9/2008):

SMR

Neurofeedback in 1980’s used Analog Equipment not feasible for general clinical use

:

Too Expensive

Too Cumbersome

Too Time consuming

Time

to revisit SMR for Insomnia with Digital equipment and new training methods

.

Slide7

Pilot Study Overview

:

IRB approved 8/2008

Purpose

–Compare treatment effects of

Z score NFB

SMR & sequential, quantitative EEG (sQEEG) guided Individually Designed (IND) protocols for Rx of Insomnia.

Methods

Eight completed single-blind study

.

Intervention

–Fifteen 20-minute

sessions

Z-Score

NFB.

Pre-treatment Screening—Medical History Questionnaire

Psychiatric Diagnostic Screening Inventory (PDSQ)

plus:

Pre-post measures

Insomnia

Severity Index (ISI

)

Pittsburgh Sleep Quality Index (PSQI

)

Psychopathology (MMPI-2-RF)

Clinical Interview Satisfaction/Happiness Quality of Life Index (QOLI)

sQEEGSlide8

PARTICIPANTS:

25+

Telephone Screening –unpaid, recruited over 4 months

Exclusions

—use of sleep aids, psychotropic meds,

meds that impact sleep, mental disorders, physical

disorders that

could

interfere

,

prior

NFB

,

enrolled

in another sleep

study

,

pregnant or shift worker

12

Selected/Met DSM 307.44 criteria

2 Declined to

start due to

personal/extraneous reasons

2 Dropped

out due to personal/external

reasons >8 visitsSlide9
Slide10

Sleep Measures

ISI=

Insomnia Severity Index--

Perceived

Severity

of Symptoms

+ Daytime

Dysfunctions for past 1-2

weeks

PSQI=Pittsburgh Sleep Quality Inventory--

General Sleep Disturbance

+ Daytime

Dysfunctions for

past

1

month

Daily Sleep

Diaries=

from

Screening Visits to Post Testing--

recordings of bedtime, rising time, estimated latency, WASO, TST, Sleep Quality 1-10, adverse events or unusual

circumstances

Actiwatch=

72

hours pre and post treatmentSlide11

Measures of Daytime Functioning

MMPI-2

RF

-

Most

widely researched, used measure of psychopathology. Newest version

Psychiatric Diagnostic

Screening-

Questionnaire-

PDSQ—Guide to depth clinical interview to confirm absent Dx

Quality of Life Index-QOLI—

Measures positive

mental health=daytime

function

Slide12

Objective Physiological Measures

sQEEG=Quantitative

Electroencephalogram

Profiles

the brain’s electrical functioning

in direct comparison

with normative

database (NeuroGuide).

Like

other direct physiological measures, such as blood sugar, lipids or liver enzymes, the EEG

has

demonstrated high

reliability

Actiwatch

-

Numerous technical difficulties invalidated useSlide13

sQEEG—EEG General Screening

Records several minutes at 4 scalp sites in

5 runs for total of 19 of 10/20 sites

Records overall synchrony measures

between

each set of 4 sites

BrainMaster Certified

Calibration tested EEG

amplifier

for

NFB/QEEGSlide14

NFB=Operant Conditioning to Norm

Training to Norm =Normalizing physiological process

via self-regulating brainwave distribution

Based on Principles of Learning via

Operant Conditioning

Z-Score

NFB designed to use Live, Instantaneous record as basis of ReinforcementSlide15

Experimental Groups

Group 1—

Z-Score Individualized Protocol (IND) = Normalized 4 highest abnormal site(s) (HAS4) via reward of correct enhancement or inhibition of variables > ±1.96

Z

, at increasingly larger percentage of normal

Z

scores. Modified PZOKUL.

Group 2—

Z

-Score SMR Protocol (SMR) =

Training at Cz and C4, LE, reward production of SMR (12-15Hz) & inhibition of excessive theta & high beta, & all other amplitudes & connectivity measures within normal. Modified PZOKUL .

General Training Procedure =

I

nitial % of all variables in the normal range =50% raised as % Time >80

Z

scores normal. When % variables >80,

Z

score limit was reduced as far as possible.

Slide16
Slide17

Success of Training

All subjects reached training goal of 80% correct within normal range for 80% of the training time.

Four of 5 in SMR improved SMR Z-scores (toward 0) at training sites ANOVA Age, sex, PDSQ, Group not significant covariates.

Groups combined for all measures.

Pre-Post Significant Changes

Significant improvement on all primary sleep measures. See Table 2 & 3, Figs 2 & 3

Sleep Efficiency above diagnostic cutoff Post treatment

WASO significantly improved in half.

QOLI significantly improved

MMPI clinical improvement

sQEEG significant lowering of Delta (sleepiness) & Beta (arousal) Table 4

Six month Follow-up

Six of 8 responded

Five of 6 remained free of insomnia, one returned to baseline, 3 improved from baseline

Slide18
Slide19
Slide20
Slide21
Slide22
Slide23
Slide24

Actiwatch—

72 Hour data pre-post with Multiple Technical

Difficulties Prevented Analysis

Click sound inaudible

Possibly defective

recording hardware

Possibly defective

recording software

Vender suggested corrections via

Sleep Log

questionable

User

errors discovered

too late

to re-trainSlide25

Adverse

Events

None

reported

__________________________

Two drop-outs

Unexpected life-style changes

(trauma induced) interfering

with treatment scheduleSlide26

Conclusions

:

Baseline EEGs showed both excessive sleepiness and hyperarousal, which significantly improved post-treatment.

Both NFB protocols provided significant improvement in self reported

sleep,

daytime

functioning, mental health, and sQEEG.

SMR treatment

at

least as effective as IND,

and

significantly less burdensome to administer

.Slide27

Discussion

Data replicates early

SMR studies with new equipment and advanced software/training

designs

Z score NFB possibly effective

at 8

Rx

sessions (160”) training time, possibly faster than traditional NFB & CBT

3) SMR at least as

effective

as

Individually designed protocol based on

sQEEG

4) Participants

improved on ALL self-report sleep

measures, quality of life, and mental healthSlide28

Discussion

(

continued)

All Participants became normal sleepers, relatively quickly

6)

Safe, well-tolerated,

non-pharmacological, Non-Invasive

7) SMR easily practiced clinicallySlide29

Limitations

:

Small Sample Size

Regression toward Mean

Lack of Control group

Single Blind

Design

Lack of useful Actiwatch/objective

sleep measure

Lack of EEG connectivity measures in

IND

Slide30

I love sleep. My life has the tendency to fall apart when I'm awake, you know?

Ernest Hemingway